Evidence map›Paper›PMID 37694133›Full record

ArticleClinical medicine insights. Endocrinology and diabetes2023

Arifa Mustika, Nurmawati Fatimah, Indri Safitri, Nurlaili Susanti, Nurul Shahfiza Noor

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical medicine insights. Endocrinology and diabetes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arifa MustikaAnatomy, Histology, and Pharmacology Department, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia.ORCID https://orcid.org/0000-0001-6461-5782
Nurmawati FatimahAnatomy, Histology, and Pharmacology Department, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia.
Indri SafitriBiochemistry Department, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia.
Nurlaili SusantiBiomedical Department, Faculty of Medicine and Health Science, Maulana Malik Ibrahim State Islamic University, Malang, East Java, Indonesia.
Nurul Shahfiza NoorToxicology Department, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes mellitus-induced hyperglycemia increases oxidative stress and inflammatory cytokine production, which play a significant role in the damage and apoptosis of pancreatic β cells. Therefore, the administration of medications that can reduce oxidative stress and inflammation plays an important role in diabetes treatment. Objective: To probe the Design: An experimental laboratory in the animal model. Methods: Twenty-five diabetic rat models were randomly assigned into 5 clusters. Clusters 1, 2, and 3 were administered with Results: The average IL-6, MDA, and TNF-α levels declined in the cluster receiving Conclusion:

Indexed as

Clinacanthus nutans LDiabetesinterleukin-6Langerhans isletmalondialdehydemedicinetumor necrosis factor-α

Identifiers

PMID37694133
PMCPMC10492484

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.